Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says
January 22, 2021 at 08:57 AM EST
Johnson & Johnson is on track to analyze data from its late-stage single-dose COVID-19 vaccine trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|